Načítá se...
Real-world experience with 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN) in the United Kingdom
AIMS: To compare safety outcomes and visual function data acquired in the real-world setting with FAME study results in eyes treated with 0.2 μg/day fluocinolone acetonide (FAc). METHODS: Fourteen UK clinical sites contributed to pseudoanonymised data collected using the same electronic medical reco...
Uloženo v:
| Vydáno v: | Eye (Lond) |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5733285/ https://ncbi.nlm.nih.gov/pubmed/28737758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2017.125 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|